These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15194338)

  • 1. Immunosuppression in pancreas transplantation: mycophenolate mofetil versus sirolimus.
    Garcia VD; Keitel E; Santos AF; Bianco PD; Bittar AE; Bruno RM; Garcia CD; Vitola SP; Guerra EE; Didone E; Pires F; D'Avila AJ; Goldani JJ; Bianchini JJ
    Transplant Proc; 2004 May; 36(4):975-7. PubMed ID: 15194338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB
    Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar early complication rate in simultaneous pancreas and kidney recipients on tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus immunosuppressive regimens.
    Girman P; Lipar K; Koznarova R; Boucek P; Kriz J; Kocik M; Havrdova T; Adamec M; Saudek F
    Transplant Proc; 2010; 42(6):1999-2002. PubMed ID: 20692391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of sirolimus rescue in kidney-pancreas transplantation.
    Rogers J; Ashcraft EE; Baliga PK; Chavin KD; Lin A; Emovon O; Afzal F; Baillie GM; Taber DJ; Alvarez S; Pullatt RC; Rajagopalan PR
    Transplant Proc; 2004 May; 36(4):1058-60. PubMed ID: 15194367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of tacrolimus-sirolimus maintenance immunosuppression on proteinuria and kidney function in pancreas transplant alone recipients.
    Kandula P; Fridell J; Taber TE; Sharfuddin A; Yaqub MS; Phillips CL; Chen J; Mujtaba M
    Transplantation; 2012 Nov; 94(9):940-6. PubMed ID: 23037007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excellent outcomes can be achieved in young pancreas transplant alone recipients by addition of sirolimus to maintenance immunosuppression regimen.
    Porubsky M; Gruessner AC; Rana A; Jie T; Gruessner RW
    Transplant Proc; 2014; 46(6):1932-5. PubMed ID: 25131074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo use of sirolimus in immunosuppression regimens in kidney and kidney-pancreas transplantation at the University of California, San Francisco.
    Vincenti F; Stock P
    Transplant Proc; 2003 May; 35(3 Suppl):183S-186S. PubMed ID: 12742494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
    Gonwa T; Mendez R; Yang HC; Weinstein S; Jensik S; Steinberg S;
    Transplantation; 2003 Apr; 75(8):1213-20. PubMed ID: 12717205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with sirolimus for calcineurin minimization/elimination in pancreas-after-kidney transplantation.
    Gautam A; Morrissey PE; Gohh R; Yango A; Monaco AP
    Transplant Proc; 2005 Oct; 37(8):3542-3. PubMed ID: 16298654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of mycophenolate mofetil and sirolimus in prevention of acute heart, pancreas, and kidney allograft rejection and in reversal of ongoing heart allograft rejection in the rat.
    Vu MD; Qi S; Xu D; Wu J; Peng J; Daloze P; Sehgal S; Leduc B; Chen H
    Transplantation; 1998 Dec; 66(12):1575-80. PubMed ID: 9884242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid-free maintenance immunosuppression with rapamune and low-dose neoral in pancreas transplant recipients.
    Rajab A; Pelletier RP; Ferguson RM; Elkhammas EA; Bumgardner GL; Henry ML
    Transplantation; 2007 Nov; 84(9):1131-7. PubMed ID: 17998868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can we maintain immunosuppression avoiding nephrotoxic agents in pancreas transplantation?
    Kandaswamy R; Dunn T; Humar A; Sutherland DE
    Transplant Proc; 2008 Mar; 40(2):516-7. PubMed ID: 18374118
    [No Abstract]   [Full Text] [Related]  

  • 14. Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs.
    Flechner SM; Goldfarb D; Solez K; Modlin CS; Mastroianni B; Savas K; Babineau D; Kurian S; Salomon D; Novick AC; Cook DJ
    Transplantation; 2007 Apr; 83(7):883-92. PubMed ID: 17460558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion to sirolimus in kidney-pancreas and pancreas transplantation.
    Matias P; Araujo MR; Romão JE; Abensur H; Noronha IL
    Transplant Proc; 2008 Dec; 40(10):3601-5. PubMed ID: 19100448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic effect of sirolimus versus mycophenolate mofetil on pancreatic graft function in the early posttransplant period.
    Havrdova T; Saudek F; Boucek P; Adamec M; Koznarova R; Jedinakova T; Karasova L; Skibova J
    Transplant Proc; 2005 Oct; 37(8):3544-5. PubMed ID: 16298655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation.
    Freise CE; Kang SM; Feng S; Hirose R; Stock P
    Arch Surg; 2003 Oct; 138(10):1121-5; discussion 1125-6. PubMed ID: 14557130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid metabolism in renal transplant patients receiving tacrolimus/sirolimus combination therapy.
    Wlodarczyk Z; Vitko S; Salmela K; Czajkowski Z; Margreiter R;
    Transplant Proc; 2005 May; 37(4):1871-3. PubMed ID: 15919489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
    Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
    Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in immunosuppression after pancreas transplantation: what is in the pipeline?
    Kimelman M; Brandacher G
    Curr Opin Organ Transplant; 2013 Feb; 18(1):76-82. PubMed ID: 23254700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.